Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine–pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso

Table 3 Risk factors associated with the Pfdhfr intermediate-to-high resistance

Variable	N	≥2 Pfdhfr mutations (%)	Adjusted OR (95% CI)^a	P value
Time between last SP dose and the survey
No IPTp-SP	52	32 (61.5)	1
Early IPTp-SP	19	10 (52.6)	0.61 (0.20–1.86)	0.38
Recent IPTp-SP	30	25 (83.3)	3.45 (1.18–10.07)	0.023

^aMultivariable analysis using logistic regression adjusted for residence, age, and gravidity

ISSN: 1475-2875